Wealthquest’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$414K Buy
1,070
+78
+8% +$28.9K 0.03% 110
2026
Q1
$290K Sell
992
-84
-8% -$27.6K 0.02% 115
2025
Q4
$377K Buy
+1,076
New +$364K 0.03% 98
2025
Q3
Sell
-935
Closed -$364K 66
2025
Q2
$364K Sell
935
-10
-1% -$4.02K 0.03% 93
2025
Q1
$411K Buy
+945
New +$379K 0.03% 81
2023
Q4
Sell
-565
Closed -$246K 135
2023
Q3
$246K Buy
565
+5
+0.9% +$2.27K 0.03% 116
2023
Q2
$249K Hold
560
0.03% 109
2023
Q1
$257K Hold
560
0.03% 105
2022
Q4
$287K Sell
560
-5
-0.9% -$2.54K 0.04% 99
2022
Q3
$256K Buy
565
+5
+0.9% +$2.39K 0.04% 102
2022
Q2
$270K Hold
560
0.04% 100
2022
Q1
$259K Hold
560
0.04% 121
2021
Q4
$259K Hold
560
0.04% 121
2021
Q3
$208K Sell
560
-212
-27% -$80.6K 0.04% 131
2021
Q2
$294K Hold
772
0.05% 110
2021
Q1
$277K Hold
772
0.05% 111
2020
Q4
$247K Hold
772
0.05% 111
2020
Q3
$207K Hold
772
0.05% 107
2020
Q2
$203K Buy
+772
New +$206K 0.05% 106
2019
Q4
$234K Buy
+776
New +$214K 0.07% 120
2019
Q3
Sell
-776
Closed -$218K 132
2019
Q2
$218K Hold
776
0.08% 117
2019
Q1
$222K Buy
776
+4
+0.5% +$1.16K 0.08% 121
2018
Q4
$202K Buy
+772
New +$212K 0.08% 127

Other funds holding ELV

Wealthquest's ELV Position: Q2 2026 in Review

Wealthquest increased its Elevance Health (ELV) stake by 7.9% in Q2 2026, buying an estimated $28.9K and bringing the position to 1,070 shares worth $414K. The position accounts for 0.03% of the portfolio, ranked #110.

Wealthquest first reported a position in ELV in Q4 2018 and has held it in 23 quarters since. 437 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Wealthquest held 1,070 shares of Elevance Health worth $414K as of Q2 2026.
  • Wealthquest bought 78 Elevance Health shares in Q2 2026, an estimated $28.9K.
  • Elevance Health made up 0.03% of Wealthquest's portfolio in Q2 2026, its #110 holding.
  • Wealthquest first reported a position in Elevance Health in Q4 2018 and has held it in 23 quarters since.
  • 437 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Wealthquest's 13F filing for Q2 2026, filed 23 Jul 2026.